• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腔内与组织间混合近距离放射治疗对局部晚期宫颈癌区域淋巴结转移及B点的剂量贡献

Dose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer.

作者信息

Muramoto Yoichi, Murakami Naoya, Okonogi Noriyuki, Takatsu Jun, Iijima Kotaro, Inoue Tatsuya, Kato Kanade, Karino Tatsuki, Kojima Kanako, Oshima Masaki, Kosugi Yasuo, Kawamoto Terufumi, Hirayama Takashi, Fujino Kazunari, Terao Yasuhisa, Shikama Naoto

机构信息

Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

出版信息

Cancers (Basel). 2024 Jun 28;16(13):2384. doi: 10.3390/cancers16132384.

DOI:10.3390/cancers16132384
PMID:39001446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11240443/
Abstract

PURPOSE

Analyzing dose distributions to regional lymph-node metastases (RLNMs) in locally advanced cervical cancer (LACC) patients undergoing intracavitary and interstitial hybrid brachytherapy (IC/IS).

METHODS

Dose distributions of eleven LACC patients with 38 RLNMs, and who received 38 IC/IS sessions were analyzed in EQD, considering RLNM positions and ipsilateral interstitial needles; these RLNMs, excepting the para-aortic region, were classified into four groups.

RESULTS

RLNMs had a median of two ipsilateral interstitial needles per session. Significant differences were observed in total RLNM D, depending on whether the position was cranial or caudal of the uterine base (85.5 vs. 378.9 cGy, < 0.0001), and whether the RLNM D was associated with a number of ipsilateral interstitial needles between 0-1 or 2 or more (68.4 vs. 112.2 cGy, = 0.006) per session. At each session, Group 1 RLNMs (cranial of the uterine base, 0-1 ipsilateral interstitial needle) had a mean D of 21.1 cGy; Group 2 (cranial, 2 or more), 73.8; Group 3 (caudal, 0-1), 94.7; and Group 4 (caudal, 2 or more), 136.1.

CONCLUSION

RLNMs located caudal of the uterine base associated with two or more ipsilateral interstitial needles in IC/IS had a higher dose contribution, which should be considered when calculating the RLNMs' dose of external beam boost irradiation.

摘要

目的

分析局部晚期宫颈癌(LACC)患者在接受腔内和组织间混合近距离放疗(IC/IS)时区域淋巴结转移灶(RLNM)的剂量分布。

方法

对11例有38个RLNM且接受了38次IC/IS治疗的LACC患者的剂量分布进行等效剂量分析,考虑RLNM位置和同侧组织间针;除主动脉旁区域外,这些RLNM被分为四组。

结果

每次治疗中RLNM同侧组织间针的中位数为两根。根据RLNM位于子宫底部的头侧还是尾侧(85.5 vs. 378.9 cGy,<0.0001),以及每次治疗中RLNM的剂量是否与同侧组织间针数量在0 - 1根或2根及以上有关(68.4 vs. 112.2 cGy,=0.006),观察到RLNM总剂量存在显著差异。每次治疗时,第1组RLNM(子宫底部头侧,0 - 1根同侧组织间针)的平均剂量为21.1 cGy;第2组(头侧,2根及以上)为73.8 cGy;第3组(尾侧,0 - 1根)为94.7 cGy;第4组(尾侧,2根及以上)为136.1 cGy。

结论

在IC/IS治疗中,位于子宫底部尾侧且与两根或更多同侧组织间针相关的RLNM剂量贡献更高,在计算RLNM外照射剂量增强时应予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dad/11240443/d37cb22d7f81/cancers-16-02384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dad/11240443/f20d554519a0/cancers-16-02384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dad/11240443/d37cb22d7f81/cancers-16-02384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dad/11240443/f20d554519a0/cancers-16-02384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dad/11240443/d37cb22d7f81/cancers-16-02384-g002.jpg

相似文献

1
Dose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer.腔内与组织间混合近距离放射治疗对局部晚期宫颈癌区域淋巴结转移及B点的剂量贡献
Cancers (Basel). 2024 Jun 28;16(13):2384. doi: 10.3390/cancers16132384.
2
Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.仅用于局部晚期宫颈癌的间质针与腔内施源器:来自实际剂量学比较的结果
Front Oncol. 2024 Mar 19;14:1347727. doi: 10.3389/fonc.2024.1347727. eCollection 2024.
3
Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.局部晚期宫颈癌中包括斜针在内的腔内/间质联合近距离放疗的特征。
Brachytherapy. 2021 Jul-Aug;20(4):796-806. doi: 10.1016/j.brachy.2021.03.019. Epub 2021 May 14.
4
Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.宫颈癌患者3D图像引导近距离放射治疗的长期经验及临床结果
Radiother Oncol. 2016 Sep;120(3):447-454. doi: 10.1016/j.radonc.2016.04.016. Epub 2016 May 2.
5
Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.腔内/组织间施源器联合子宫旁远端游离针组织间近距离放疗在局部晚期宫颈癌中的剂量学研究
Front Oncol. 2021 Feb 18;10:621347. doi: 10.3389/fonc.2020.621347. eCollection 2020.
6
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.图像引导自适应近距离治疗晚期宫颈癌侵犯膀胱和/或直肠:临床结果和预后因素。
Gynecol Oncol. 2023 Jan;168:32-38. doi: 10.1016/j.ygyno.2022.11.002. Epub 2022 Nov 9.
7
Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.间质环型针不应用于使用 Venezia 施源器进行宫腔内/间质近距离放疗的宫颈癌患者:病例报告。
BMC Womens Health. 2024 Apr 18;24(1):249. doi: 10.1186/s12905-024-03091-2.
8
Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.使用新型混合施源器Venezia对宫颈癌进行腔内和组织间联合近距离放射治疗:临床可行性及初步结果
Brachytherapy. 2018 Sep-Oct;17(5):775-781. doi: 10.1016/j.brachy.2018.05.009. Epub 2018 Jun 22.
9
Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.局部晚期宫颈癌腔内(Fletcher)与联合腔内/间质(乌得勒支)近距离放疗的剂量学参数比较和结果。
Brachytherapy. 2024 Jan-Feb;23(1):10-17. doi: 10.1016/j.brachy.2023.09.004. Epub 2023 Oct 7.
10
Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.临床应用乌得勒支施源器行腔内/间质近距离联合放疗治疗局部晚期宫颈癌。
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1424-30. doi: 10.1016/j.ijrobp.2011.04.044. Epub 2011 Jun 12.

引用本文的文献

1
Optimizing dwell time weight for interstitial needles in intracavitary/interstitial hybrid brachytherapy: balancing tumor coverage with organ sparing using the inverse planning technique.腔内/组织间混合近距离放射治疗中组织间针的驻留时间权重优化:使用逆向计划技术平衡肿瘤覆盖与器官保护
J Radiat Res. 2025 May 23;66(3):296-305. doi: 10.1093/jrr/rraf025.

本文引用的文献

1
Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.使用凝胶间隔物在直肠阴道和膀胱子宫隔中安全地进行子宫颈近距离放射治疗的剂量递增和分割次数减少:一项计划研究。
Brachytherapy. 2024 Mar-Apr;23(2):115-122. doi: 10.1016/j.brachy.2023.10.003. Epub 2023 Nov 30.
2
Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.美国宫颈癌近距离放疗利用的最新趋势:一项监测、流行病学和最终结果研究。
Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):143-153. doi: 10.1016/j.ijrobp.2023.11.007. Epub 2023 Nov 10.
3
MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience.
MucoUp®作为子宫颈癌近距离放射治疗中的间隔器:首例人体试验经验。
Clin Transl Radiat Oncol. 2023 Jul 17;42:100659. doi: 10.1016/j.ctro.2023.100659. eCollection 2023 Sep.
4
In Reply to Murakami et al.致村上等人的回复
Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):964-965. doi: 10.1016/j.ijrobp.2023.03.070.
5
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.ESGO/ESTRO/ESP 宫颈癌管理指南-2023 年更新版。
Radiother Oncol. 2023 Jul;184:109682. doi: 10.1016/j.radonc.2023.109682. Epub 2023 May 1.
6
ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.ESGO/ESTRO 宫颈癌放射治疗质量指标。
Radiother Oncol. 2023 Jun;183:109589. doi: 10.1016/j.radonc.2023.109589.
7
Hands-on seminar for image-guided adaptive brachytherapy and intracavitary/interstitial brachytherapy for uterine cervical cancer.宫颈癌图像引导自适应近距离放疗和腔内/间质近距离放疗实操研讨会。
Jpn J Clin Oncol. 2023 Jun 1;53(6):508-513. doi: 10.1093/jjco/hyad012.
8
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer.局部晚期宫颈癌腔内与间质插植混合近距离治疗的Ⅰ/Ⅱ期前瞻性临床试验。
J Gynecol Oncol. 2023 May;34(3):e24. doi: 10.3802/jgo.2023.34.e24. Epub 2022 Dec 21.
9
Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Cancer.宫颈癌原发放化疗期间影像学检查阳性的盆腔和/或腹主动脉旁淋巴结的管理
Pract Radiat Oncol. 2023 May-Jun;13(3):246-250. doi: 10.1016/j.prro.2022.11.010. Epub 2022 Dec 16.
10
Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer.透明质酸注射对宫颈癌近距离放疗中剂量-体积参数的影响。
Adv Radiat Oncol. 2022 Feb 6;7(3):100918. doi: 10.1016/j.adro.2022.100918. eCollection 2022 May-Jun.